A novel synthetic compound overcomes drug resistance on EGFR (T790M) and cancer stemness in human non-small cell lung cancer

被引：0
|
作者：
Pan, Pei Ying [1 ]
Chang, Chien-Jen [2 ]
Liu, Kuang-Kai [2 ]
Chan, Yu-Chi [2 ]
Chen, Yan-Ting [2 ]
Chao, Jui-I [2 ]
机构：
[1] Natl Chiao Tung Univ, Bioinformat & Syst Biol, Hsinchu, Taiwan
[2] Natl Chiao Tung Univ, Hsinchu, Taiwan
来源：
FASEB JOURNAL | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
lb181
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SP101, a novel synthetic compound reduces the drug resistance of EGFR(T790M) and cancerous stemness in non-small cell lung carcinoma
    Chao, Jui-I
    FASEB JOURNAL, 2016, 30
  • [2] CO-1686, a novel mutant selective EGFR inhibitor, overcomes T790M mediated resistance in Non-Small Cell Lung Cancer (NSCLC)
    Walter, Annette O.
    Tjin, Robert
    Haringsma, Henry
    Lin, Kevin
    Dubrovskiy, Alex
    Lee, Kwangho
    St Martin, Thia
    Karp, Russell
    Zhu, Zhendong
    Nu, Deqiang
    Nacht, Mariana
    Suda, Kenichi
    Mitsudomi, Tetsuya
    Petter, Russell C.
    Westlin, William F.
    Singh, Juswinder
    Raponi, Mitch
    Allen, Andrew
    CANCER RESEARCH, 2012, 72
  • [3] Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer
    Li, Yanxia
    Song, Zhendong
    Jin, Yue
    Tang, Zeyao
    Kang, Jian
    Ma, Xiaodong
    MOLECULES, 2016, 21 (11)
  • [4] Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer
    John, Thomas
    Bowden, Jeffrey J.
    Clarke, Stephen
    Fox, Stephen B.
    Garrett, Kerryn
    Horwood, Keith
    Karapetis, Christos S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (04) : 296 - 303
  • [5] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hirano, Toshiyuki
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
  • [6] Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR
    Hwang, Ki-Eun
    Kwon, Su-Jin
    Kim, Young-Suk
    Park, Do-Sim
    Kim, Byoung-Ryun
    Yoon, Kwon-Ha
    Jeong, Eun-Taik
    Kim, Hak-Ryul
    EXPERIMENTAL CELL RESEARCH, 2014, 323 (02) : 288 - 296
  • [7] A small-molecule compound D6 overcomes EGFR-T790M-mediated resistance in non-small cell lung cancer
    Xiaolong Tang
    Lizhi Cheng
    Guo Li
    Yong-Ming Yan
    Fengting Su
    Dan-Ling Huang
    Shuping Zhang
    Zuojun Liu
    Minxian Qian
    Ji Li
    Yong-Xian Cheng
    Baohua Liu
    Communications Biology, 4
  • [8] REVERSAL OF RESISTANCE TO EGFR TYROSINE KINASE INHIBITOR BY EGFR T790M SPECIFIC SIRNA IN NON-SMALL CELL LUNG CANCER
    Lee, Choon-Taek
    Park, Mi-Young
    Eo, Eun Young
    Park, Jong Sun
    Cho, Young Jae
    Yoon, Ho-Il
    Lee, Jae Ho
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S458 - S458
  • [9] A small-molecule compound D6 overcomes EGFR-T790M-mediated resistance in non-small cell lung cancer
    Tang, Xiaolong
    Cheng, Lizhi
    Li, Guo
    Yan, Yong-Ming
    Su, Fengting
    Huang, Dan-Ling
    Zhang, Shuping
    Liu, Zuojun
    Qian, Minxian
    Li, Ji
    Cheng, Yong-Xian
    Liu, Baohua
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [10] EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Sakakibara, Rie
    Saiki, Masafumi
    Ariyasu, Ryo
    Koyama, Junji
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Ohyanagi, Fumiyoshi
    Ninomiya, Hironori
    Ishikawa, Yuichi
    Nishio, Makoto
    RESPIRATORY MEDICINE CASE REPORTS, 2018, 24 : 19 - 21
12345